
Michael D. Pak
Examiner (ID: 3628, Phone: (571)272-0879 , Office: P/1646 )
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1674, 1621, 1646, 1812, 0 |
| Total Applications | 1549 |
| Issued Applications | 718 |
| Pending Applications | 268 |
| Abandoned Applications | 570 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6202875
[patent_doc_number] => 20110065661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'PHARMACOPERONES FOR CORRECTING DISEASE STATES INVOLVING PROTEIN MISFOLDING'
[patent_app_type] => utility
[patent_app_number] => 12/953822
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 33032
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065661.pdf
[firstpage_image] =>[orig_patent_app_number] => 12953822
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/953822 | PHARMACOPERONES FOR CORRECTING DISEASE STATES INVOLVING PROTEIN MISFOLDING | Nov 23, 2010 | Abandoned |
Array
(
[id] => 8429640
[patent_doc_number] => 20120251514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'MODULATED PROGRAMMED DEATH LIGAND-1'
[patent_app_type] => utility
[patent_app_number] => 13/509476
[patent_app_country] => US
[patent_app_date] => 2010-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19359
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509476
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/509476 | MODULATED PROGRAMMED DEATH LIGAND-1 | Nov 11, 2010 | Abandoned |
Array
(
[id] => 8759815
[patent_doc_number] => 08420334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Method for detecting invasive microvesicles derived from tumor cells'
[patent_app_type] => utility
[patent_app_number] => 12/942858
[patent_app_country] => US
[patent_app_date] => 2010-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 7638
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12942858
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/942858 | Method for detecting invasive microvesicles derived from tumor cells | Nov 8, 2010 | Issued |
Array
(
[id] => 6120880
[patent_doc_number] => 20110077207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'METHOD FOR TREATING INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 12/942302
[patent_app_country] => US
[patent_app_date] => 2010-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12067
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077207.pdf
[firstpage_image] =>[orig_patent_app_number] => 12942302
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/942302 | METHOD FOR TREATING INFLAMMATION | Nov 8, 2010 | Abandoned |
Array
(
[id] => 8522678
[patent_doc_number] => 20120322085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES OR ALLERGY, AND METHOD FOR SCREENING FOR THE THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/508192
[patent_app_country] => US
[patent_app_date] => 2010-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 29397
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508192
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508192 | THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES OR ALLERGY, AND METHOD FOR SCREENING FOR THE THERAPEUTIC AGENT | Nov 4, 2010 | Abandoned |
Array
(
[id] => 6126616
[patent_doc_number] => 20110086389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'Compositions and Methods for Expressing In-Frame Multimeric Proteins'
[patent_app_type] => utility
[patent_app_number] => 12/915333
[patent_app_country] => US
[patent_app_date] => 2010-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17585
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086389.pdf
[firstpage_image] =>[orig_patent_app_number] => 12915333
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/915333 | Compositions and Methods for Expressing In-Frame Multimeric Proteins | Oct 28, 2010 | Abandoned |
Array
(
[id] => 4634253
[patent_doc_number] => 08012702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-06
[patent_title] => 'H+-gated ion channel'
[patent_app_type] => utility
[patent_app_number] => 12/905647
[patent_app_country] => US
[patent_app_date] => 2010-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 11320
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/012/08012702.pdf
[firstpage_image] =>[orig_patent_app_number] => 12905647
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/905647 | H+-gated ion channel | Oct 14, 2010 | Issued |
Array
(
[id] => 10018512
[patent_doc_number] => 09060981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Marker associated with non-alcoholic steatohepatitis'
[patent_app_type] => utility
[patent_app_number] => 13/500753
[patent_app_country] => US
[patent_app_date] => 2010-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 14322
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500753
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/500753 | Marker associated with non-alcoholic steatohepatitis | Oct 14, 2010 | Issued |
Array
(
[id] => 8335520
[patent_doc_number] => 20120202222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'ENZYME FRAGMENT COMPLEMENTATION ASSAYS FOR MONITORING THE ACTIVATION OF THE VOLTAGE-GATED POTASSIUM ION CHANNEL HERG'
[patent_app_type] => utility
[patent_app_number] => 13/501782
[patent_app_country] => US
[patent_app_date] => 2010-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15353
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501782
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/501782 | ENZYME FRAGMENT COMPLEMENTATION ASSAYS FOR MONITORING THE ACTIVATION OF THE VOLTAGE-GATED POTASSIUM ION CHANNEL HERG | Oct 11, 2010 | Abandoned |
Array
(
[id] => 8282697
[patent_doc_number] => 08216798
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration'
[patent_app_type] => utility
[patent_app_number] => 12/896522
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10038
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12896522
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/896522 | Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration | Sep 30, 2010 | Issued |
Array
(
[id] => 4608666
[patent_doc_number] => 07993921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-09
[patent_title] => 'Cell cycle regulation and differentiation'
[patent_app_type] => utility
[patent_app_number] => 12/892760
[patent_app_country] => US
[patent_app_date] => 2010-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 104
[patent_figures_cnt] => 121
[patent_no_of_words] => 32099
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/993/07993921.pdf
[firstpage_image] =>[orig_patent_app_number] => 12892760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/892760 | Cell cycle regulation and differentiation | Sep 27, 2010 | Issued |
Array
(
[id] => 7560860
[patent_doc_number] => 20110274692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'Screening Methods'
[patent_app_type] => utility
[patent_app_number] => 12/890590
[patent_app_country] => US
[patent_app_date] => 2010-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 55961
[patent_no_of_claims] => 153
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20110274692.pdf
[firstpage_image] =>[orig_patent_app_number] => 12890590
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/890590 | Screening methods | Sep 23, 2010 | Issued |
Array
(
[id] => 5985652
[patent_doc_number] => 20110097794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/888732
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 30712
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097794.pdf
[firstpage_image] =>[orig_patent_app_number] => 12888732
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/888732 | Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof | Sep 22, 2010 | Issued |
Array
(
[id] => 8301003
[patent_doc_number] => 20120183564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'INHIBITION OF ENDOSOMAL TOLL-LIKE RECEPTOR ACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 13/496313
[patent_app_country] => US
[patent_app_date] => 2010-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6830
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496313
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/496313 | Inhibition of endosomal toll-like receptor activation | Sep 15, 2010 | Issued |
| 09/129758 | MAMMAL NEURONAL ACID SENSING CATIONIC CHANNEL, CLONING AND APPLICATIONS THEREOF. | Sep 14, 2010 | Abandoned |
Array
(
[id] => 6176179
[patent_doc_number] => 20110177612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/881014
[patent_app_country] => US
[patent_app_date] => 2010-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 99827
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177612.pdf
[firstpage_image] =>[orig_patent_app_number] => 12881014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/881014 | Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders | Sep 12, 2010 | Abandoned |
Array
(
[id] => 6007447
[patent_doc_number] => 20110059478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'Orphan Nuclear Receptor'
[patent_app_type] => utility
[patent_app_number] => 12/877195
[patent_app_country] => US
[patent_app_date] => 2010-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9772
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059478.pdf
[firstpage_image] =>[orig_patent_app_number] => 12877195
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/877195 | Orphan nuclear receptor | Sep 7, 2010 | Issued |
Array
(
[id] => 8516247
[patent_doc_number] => 20120315649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE'
[patent_app_type] => utility
[patent_app_number] => 13/393075
[patent_app_country] => US
[patent_app_date] => 2010-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72836
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393075
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/393075 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | Aug 26, 2010 | Abandoned |
Array
(
[id] => 6026843
[patent_doc_number] => 20110054147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'MOLECULAR WEIGHT MARKERS FOR MEMBRANE PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/870450
[patent_app_country] => US
[patent_app_date] => 2010-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5548
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20110054147.pdf
[firstpage_image] =>[orig_patent_app_number] => 12870450
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/870450 | Molecular weight markers for membrane proteins | Aug 26, 2010 | Issued |
Array
(
[id] => 7744288
[patent_doc_number] => 20120021998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Cancer Diagnosis and Treatment Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/839754
[patent_app_country] => US
[patent_app_date] => 2010-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3087
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021998.pdf
[firstpage_image] =>[orig_patent_app_number] => 12839754
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/839754 | Cancer Diagnosis and Treatment Methods of Use | Jul 19, 2010 | Abandoned |